Funding for this research was provided by:
Ligue Contre le Cancer
Institut National Du Cancer (INCa_13539)
Agence Nationale de la Recherche (ANR-10-COHO-0006)
Ministère de l'Enseignement supérieur, de la Recherche et de l'Innovation (#2102 918823)
Received: 19 January 2021
Accepted: 10 May 2021
First Online: 2 August 2021
: The E3N cohort was conducted in accordance with the Declaration of Helsinki and received ethical approval from the French National Commission for Data Protection and Privacy. Participants provided written informed consent.This study is listed at ExternalRef removed as NCT03285230.
: Not applicable.
: Marc J. Gunter is a member of the editorial board for BMC Medicine. The other authors declare that they have no competing interests.